Company intelligence / Profile preview

Taiwan Biophotonic

Hsinchu Shih, Hsinchu, Taiwantbpchc.com ↗

Ownership: Private
Employees: ~22
Development stage: Other

Overview

Taiwan Biophotonic has developed and commercialized the oCare Pro 100 wrist pulse oximeter—the first finger-free reflective optical sensor for continuous non-invasive monitoring of heart rate and blood oxygen saturation. The device is FDA 510(k) cleared and CE marked. The company also develops technologies for non-contact blood glucose measurement and other wearable health devices. Clinical results support its use in hospital and home settings for chronic disease management.

Therapeutic areas: PulmonologyEndocrinology
Modalities: DeviceWearable medical deviceNon-invasive physiological monitoring technology
Industry: Physiological Monitoring

Partnerships

Industrial Technology Research Institute (ITRI)—founding technical partner/investor

Beyond the preview

Go deeper on Taiwan Biophotonic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taiwan Biophotonic.

Explore the full profile